Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
No therapeutic, diagnostic, or clinical claim is made or implied
TNB-738 is a biparatopic antibody specifically designed to inhibit CD38 by binding to two distinct epitopes on the CD38 molecule simultaneously, thereby enhancing its inhibitory effect on CD38s enzymatic activity 156
Mol Pharm 22:11001109
This hormone plays a crucial role in glucose metabolism and appetite regulation
Evidence from the SURPASS phase III clinical trial program has consistently demonstrated the superior metabolic efficacy of tirzepatide compared with currently available GLP-1 receptor agonists, such as semaglutide
While the specific amount needed varies by individual and climate, most adults benefit from drinking approximately two liters of fluids daily, adjusting for activity level and environmental conditions
US$ 25.63
US$ 26.40
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 26.45
